awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26765609-DF9E1A5F-295F-47DA-B9C5-9C2413720DFF
Q26765609-DF9E1A5F-295F-47DA-B9C5-9C2413720DFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26765609-DF9E1A5F-295F-47DA-B9C5-9C2413720DFF
The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
P2860
Q26765609-DF9E1A5F-295F-47DA-B9C5-9C2413720DFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26765609-DF9E1A5F-295F-47DA-B9C5-9C2413720DFF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
852654973c6da20a9b225c1f50342a609feac5b5
P2860
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.